Dr. Andrew Paulson, MD
What this data tells you about Dr. Paulson
Dr. Andrew Paulson is a medical oncology specialist in Dallas, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Paulson performed 31,696 Medicare services across 2,011 unique beneficiaries.
Between the years covered by Open Payments, Dr. Paulson received a total of $68,681 from 23 pharmaceutical and/or device companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Paulson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) | 5,700 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 5,200 | $43 | $137 |
| Injection, lanreotide, 1 mg | 4,920 | $43 | $227 |
| Contrast dye for imaging (iodine-based) | 4,681 | $0 | $3 |
| Paclitaxel chemotherapy injection | 4,298 | $0 | $8 |
| Dexamethasone injection (steroid) | 1,104 | $0 | $1 |
| Comprehensive metabolic blood panel | 580 | $10 | $64 |
| Anti-nausea injection (Aloxi/palonosetron) | 580 | $1 | $114 |
| Complete blood count (CBC) with differential | 551 | $8 | $36 |
| Injection, granisetron hydrochloride, 100 mcg | 550 | $0 | $24 |
| Blood draw (venipuncture) | 503 | $8 | $20 |
| Office visit, established patient (30-39 min) | 361 | $96 | $368 |
| Gallium ga-68, dotatate, diagnostic, 0.1 millicurie | 283 | $155 | $560 |
| Injection, leucovorin calcium, per 50 mg | 255 | $3 | $25 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 225 | $3 | $373 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 219 | $23 | $157 |
| Injection, fluorouracil, 500 mg | 168 | $2 | $13 |
| Administration of chemotherapy into vein, 1 hour or less | 164 | $104 | $707 |
| Carcinoembryonic antigen (cea) protein level | 163 | $19 | $99 |
| Injection of additional new drug or substance into vein | 154 | $12 | $108 |
| Injection, carboplatin, 50 mg | 106 | $2 | $300 |
| Drug injection, under skin or into muscle | 82 | $11 | $96 |
| Injection, magnesium sulfate, per 500 mg | 68 | $1 | $6 |
| Injection, diphenhydramine hcl, up to 50 mg | 66 | $1 | $7 |
| Office visit, established patient, complex (40-54 min) | 63 | $127 | $496 |
| Hospital follow-up visit, moderate complexity | 62 | $62 | $247 |
| Injection, zoledronic acid, 1 mg | 60 | $6 | $431 |
| Administration of additional new drug or substance into vein, 1 hour or less | 51 | $52 | $344 |
| Unclassified drugs | 51 | $1 | $8 |
| Office visit, established patient (20-29 min) | 49 | $66 | $250 |
| CT scan of abdomen and pelvis with contrast | 46 | $175 | $1,067 |
| Ct scan of chest with contrast | 45 | $47 | $821 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 42 | $50 | $313 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 36 | $58 | $211 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 29 | $1,185 | $4,802 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 29 | $15 | $94 |
| Complete blood count (CBC), automated | 26 | $6 | $34 |
| Microscopic examination for white blood cells with manual cell count | 25 | $4 | $22 |
| Infusion, normal saline solution , 1000 cc | 25 | $2 | $19 |
| Reticulated (young) platelet measurement | 24 | $35 | $143 |
| Administration of chemotherapy into vein, each additional hour | 24 | $22 | $161 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 17 | $135 | $500 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 11 | $92 | $657 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (82%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Paulson is a mixed practice specialist, with above-average Medicare volume (top 28% in TX), with consulting-driven industry engagement in the top 19% of TX peers, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Paulson experienced with anti-nausea injection (fosaprepitant)?
Does Dr. Paulson receive payments from pharmaceutical companies?
How do Dr. Paulson's costs compare to other medical oncologists in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology